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Abstract 
Back ground 
Balloon valvuloplasty for stenosed mitral and pulmonary valves has been practiced with good 
results for the last two years in Ahmed Gasim Cardiac Centre, Khartoum Sudan.  
Objectives 
The aim of this study is to audit percutaneous trans-mitral balloon commissurotomy [PTMC] in 
our current set up. 
Methods 
One hundred and eight patients underwent percutaneous transvenous mitral commissurotomy 
(PTMC) from April- 2004 to December-2005 in Ahmed Gasim cardiac center.  
Results 
67% percent of the patients were females. Age range was from 13years to 65years and the mean age was 27years. 27% 
were under 21 years of age and 12% had special problems. 
The procedural success was achieved in 94.5% patients, in two patients we failed to dilate a tough septum, in other two 
the balloon got stuck  to the septum and failed to cross the MV, while two patients had successful emergency MVR (due 
to inadvertent puncture of the RA and cardiac tamponade). There was no mortality related to the procedure, significant 
mitral regurgitation of > grade 2 didn’t occur. No patient developed systemic embolization.  
Optimal results were achieved in 91.6% patients and in 92% of the patients with special problems. 
Hemodynamic data in the Cath. Lab showed left atrial mean (±SD) pressure dropped from 32 (±3.2) mmHg to 12 (±2.4) 
mmHg. LA-LV gradient dropped from an average of 25 to 5 mmHg. Echocardiographic assessment showed mean 
(±SD) mitral valve area increased from 0.86 (±0.19) cm2 to 1.9 (±0.5) cm2 (p<0.001) and PA pressure dropped from71 
(± 23) to 40 (±12) mmHg (p<0.01). 
Conclusion 
We conclude that PTMC is a safe procedure with good success rate and optimal results even in patients with special 
problems like redo and previous CVA.  
 
Introduction  
Rheumatic fever (RF) is an important 
clinical entity in developing countries, where 
rheumatic heart disease (RHD) represents an 
important cause of cardiac morbidity. Recent 
reports has documented incidence of RF as high 
as 206/100.000 and RHD prevalence as high as 
18.6/1000 though there are variations in the 
different geographical areas1- 6. 
The mitral valve (MV) is the most 
frequently affected valve. It is solely affected in 
25% and is affected with other valves in 40% of 
patients7.  
Inoue K and colleagues were the first to 
perform percutaneous trans-mitral 
commissurotomy (PTMC) in 1982. Since then 
PTMC became a standard procedure to help 
patients with MS favorable for it8.  
PTMC tends to delay the need for MV 
replacement for about ten years or more and some 
of these patients may be amenable for redo 
valvuloplasty9, 10.  
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Currently there are two main techniques for 
PTMC; the balloon and the metallic 
commissurotomy.  
Balloon commissurotomy has two major 
types, the double and the single balloon Inoue 
technique. The later has become the most popular 
world wide 11 (Fig 1). 
 
Figure 1: On the left: Colour Doppler flow across the 
stenosed MV. On the Right: 2D Echo demonstrating 




Balloon valvuloplasty is contraindicated 
when mitral stenosis is accompanied by a 
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significant mitral regurgitation (MR> grade 2), 
bilateral commissural calcification or when a 
thrombus which is mobile or situated in a high 
risk position (on the atrial septum, protruding into 
the left atrial (LA) cavity, or obstructing the mitral 
valve orifice) presents a high likelihood of 
systemic embolism. Relative contraindications 
include the presence of thrombus localized to the 
left atrial appendage and unilateral commissural 
calcification or the presence of another lesion 
which needs open heart surgery 12. 
 
Figure2:   Trans esophageal Echo demonstrating LA 
thrombus and spontaneous contrast which 




PTMC is most successful if the valve is pliable, 
the fusion is commissural and no much sub-
valvular calcification or thickening is present (Fig 
2) as assessed by Wilkins echocardiographic 
criteria i.e. score ≤ 8 (table 1). Trans esophageal 
echocardiography is needed to evaluate the 
morphology of the valve and to exclude the 
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Figure 3: Mitral valve balloon valvuloplasty, (A) Initial 
inflation, (B) moderate dilation, (C)  maximal 
dilatation.   
The most crucial step in PTMC is the trans-
septal puncture, which is best located in the fossa 
ovalis or the lower third of the inter-atrial septum 
for easy crossing of the MV by the balloon and 
the most serious complications are accidental 
puncture of the aorta or the atrial wall causing 
bleeding or tamponade. The valve dilatation may 
also lead to severe mitral regurgitation 15 . 
The successfulness of the procedure is 
measured in the Catheter Laboratory (Cath Lab) 
by the drop in the mean LA pressure and the drop 
in the trans- valvular pressure gradient. While it is 
evident by echocardiography if the mitral valve 
area (MVA) became > double the original area or 
it is increased by   >1cm2 (7, 10). 
 
PATIENTS AND METHODS 
This is a cross sectional study, conducted at 
Ahmed Gasim Cath Lab, from April-2004 to 
December 2005 
108 Patients with severe MS, who were suitable 
for PTMC (Most of them had Wilkins score <9) 
and made written consent for the procedure were 
enrolled. Patients with MR> grade2, LA thrombus 
of any type, bilateral commissural calcification or 
significant aortic valve (AV) disease were 
excluded. PTMC was done with the standard 
Inoue technique for all patients.  
Detailed clinical data, pre-dilatation trans-
thoracic and trans- esophageal echocardiography, 
a full procedural record and a post-dilatation Echo 
(within fourteen days) were accomplished for all 
patients.  
The data was analyzed using Statistical 
Package for Social Sciences (SPSS). Significance 
testing of difference between proportions was 




108 patients were studied, 67% of them 
were females. The mean (±SD) age was 27(±9.8) 
ranged from 13 to 65 years. 27% of the patients 
were < 21 years of age. 
All patients were symptomatic with NYHA 
Grade >11 and had severe MS (table 2). 
Thirteen(12%) patients were regarded to have 
special problems (three had closed mitral 
valvotomy (CMV) before, three previous embolic 
CVA, two had giant LA, two calcified valves, a 
pregnant lady and two had associated tricuspid 
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Table 1: Echocardiographic Scoring System (Adapted from Wilkins criteria) 
 
score Grade Morphology
1 1-Highly mobile with restriction of the leaflet tips only                                     Leaflet 
mobility 
2 2-Reduced mobility in mid-portion and base of leaflets 
3 3-Forward movement of valve leaflets in diastole mainly at  the base 
4 4- No or minimal forward motion of the leaflets in diastole 
 
1 1- Near normal (4-5mm) Valve 
thickness 
2 2-Midleaflet thickening, marked thickening of the margins 
3 3-Thickening extends through entire leaflet(5-8mm) 
4 4-Marked thickening of all leaflet tissue(>8-10mm) 
 
1 1-Minimal thickening of chordial structures just below the valve Sub-
valvular 
thickening 
2 2-Thickening of chordiae extending up to one third of length 
3 3-Thickening extending up to distal third of chordiae 
4 4-Extensive thickening and shortening of all chordiae  extending 
down to the papillary muscle  
 
1 1-A single area of increased echo brightness Valve 
calcification 
2 2-Scattered areas of brightness confined to leaflet margins 
3 3-Brightness extending into the mid-portion of leaflets 




Table 2: The MVA and the TR gradient Pre and Post Procedural 
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stenosis (TS) and underwent combined procedure 
for both valves). 
The procedure was successful in 
102(94.5%) patients, in two patients we failed to 
dilate a tough septum, in spite of changing the 
puncture site. In two patients the balloon was 
stuck to the septum and failed to cross the MV 
[one of them was an emergency, with intractable 
pulmonary edema had three trans-septal puncture 
and repeated septal dilatation without success and 
died later in the CCU. The remaining two patients 
had successful emergency mitral valve 
replacement [MVR], due to inadvertent puncture 
of the RA and cardiac tamponade.  
Optimal results were achieved in 91.6% of 
patients. Three patients had their valves stretched 
but without opening the commissures despite 3 to 
4 balloon inflations for each patient including a 
redo patient. All patients with special problems 
showed optimal results except this redo patient.    
Hemodynamic data in the Cath Lab showed 
a drop of the left atrial mean pressure (LAMP) 
from an average of 32 to 12 mmHg and a drop of 
the LA-LV gradient   from an average of 25 to 5 
mmHg. LV angiogram, post dilatation, showed no 
significant MR. No patient developed systemic 
embolization and there was no immediate 
mortality. 
 Echocardiographic assessment post 
procedural showed significant increase in mitral 
valve area and significant drop in pulmonary 
artery [PA] pressure and confirmed the LV 
angiographic results of no significant MR [tab 2]. 
 
DISSCUSSION  
The age and sex distribution of our patients 
was not different from the data from developing 
countries 16, 17. 
Our procedural success rate was similar to 
that reported by Nobuyoshi and colleges from 
Jaban, who studied 102 patients with a success 
rate in 92% and comparable to Arora and colleges 
from New Delhi who studied 4,838 patients with a 
success rate of (99.8%). Also, our results are in 
keeping with those of  Paul and his team at Texas 
who had 87% success rate in their 45 patients. 
This data reflects procedural success rate in 
relation  to the load of work and hence the 
experience of the centre 16-18 .  
The procedural complications in our series 
were not so different from those obtained by 
Arora 17. 
 We achieved optimal results in 91.6% of 
our patients which were comparable to that 
achieved by Arora and colleges, Nobuyoshi from 
Jaban, Yonga from Nairobi and Luiz from Brazil 
but they are different from Texas group who 
achieved optimal results in 71% of their study 
group. Of special note was the results of our 
patients who had special problems or difficult 
cases which showed optimal results in 92% of 
them 16-20 .   
 
CONCLUSION 
This study demonstrated that PTMC in our 
current set up is a safe procedure with a good 
success rate and optimal results which may save 
or delay the need for valve replacement even in 
patients with special problems (like previous 
CVA and re stenosis following CMV). 
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